Navigation Links
Cancer Vaccines: From First-in-Class to Best-in-Class?
Date:4/9/2013

d Based Cancer Vaccine Drugs 404
Table 41: Competitive Comparison of Target Strategies of Nucleic Acid Based Cancer Vaccine Drugs 405
Table 42: Pursued Target Strategies of Nucleic Acid Based Cancer Vaccine Drugs 405
Table 43: Potential Forms of Cell Therapy 407
Table 44: Vectors in Gene Therapy 408
Table 45: Overview of the Competitive Landscape of Cell Therapy Based Cancer Vaccine Drugs 408
Table 46: Competitive Comparison of Target Strategies of Cell Therapy Based Cancer Vaccine Drugs 409
Table 47: Pursued Target Strategies of Cell Therapy Based Cancer Vaccine Drugs 409
Table 48: Overview of the Competitive Landscape of Gene Therapy Based Cancer Vaccine Drugs 410
Table 49: Competitive Comparison of Target Strategies of Gene Therapy Based Cancer Vaccine Drugs 411
Table 50: Pursued Target Strategies of Gene Therapy Based Cancer Vaccine Drugs 412
Table 51: The Competition Through Close Mechanistic Approximation Among Cancer Vaccine Drugs 414
Table 52 Competitive Summary by Indication of Cancer Vaccine Drugs 418
Table 53: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Acute Lymphocytic Leukemia 420
Table 54: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Acute Myelogenous Leukemia 421
Table 55: The Competition through Close Mechanistic Approximation between Acute Myelogenous Leukemia Drugs 421
Table 56: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Acute Promyelocytic Leukemia 423
Table 57: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Anal Dysplasia 424
Table 58: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of B-cell Lymphoma 425
Table 59: Target Strategy Development Profiles of Cancer Vaccine Drugs for the Treatment of Biliary Cancer 426
Table 60: Target Strategy Development Profiles of Cancer Vaccine Drugs for th
'/>"/>
SOURCE Reportlinker
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 16 17 18 19 20

Related medicine technology :

1. NewGen Therapeutics Presents Data on NT-113, A Novel Pan-ErbB Inhibitor, at American Association of Cancer Research
2. Exosome Presents Late-Breaking Study Demonstrating Ability to Profile RNA from Archived Clinical Trial Blood Samples at 2013 American Association of Cancer Research Annual Meeting
3. Take the Skyhook Challenge and Help Beat Blood Cancer
4. Merrimack Pharmaceuticals Preclinical Research Shows MM-121 Restores Sensitivity to Anti-Estrogen Therapy and Delays Onset of Treatment Resistance in ER-Positive Breast Cancer Model
5. Positive Preclinical Data for NKTR-214, an Investigational Cancer Immunotherapy Targeting the IL-2 Receptor Complex, Presented at AACR Annual Meeting 2013
6. Penn Medicines New Center For Personalized Diagnostics Unlocks Cancers Secrets
7. Cerulean Pharma to Present Data on CRLX101s HIF-1a Inhibition at the American Association for Cancer Research Annual Meeting
8. Merrimack Pharmaceuticals Announces Top-Line Results From A Single Arm Phase 2 Advanced Lung Cancer Study In Patients With Resistance To An Anti-EGFR Tyrosine Kinase Inhibitor
9. NewLink Genetics Presents Preclinical Data on NLG919, a New Drug Candidate from a Novel Class of IDO Pathway Inhibitors for the Treatment of Cancer
10. National Cancer Organizations Issue Joint Statement On Devastating Impact Of Sequestration
11. DelMar Pharmaceuticals to Present Clinical Data from VAL-083 Brain Cancer Trial at the American Association of Cancer Research Annual Meeting
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/31/2014)... CHESTERBROOK, Pa. , July 31, 2014 /PRNewswire/ ... AUXL ), a specialty biopharmaceutical company, today ... million regulatory milestone payment from its partner Asahi ... due because of the successful submission of a ... Device Agency (PMDA) for XIAFLEX ® (collagenase ...
(Date:7/31/2014)... , 31 juli 2014 De Pfizer Clinical ... rekruteringscampagne voor gezonde vrijwilligers van Japanse komaf voor medewerking ... gevestigde PCRU is één van twee onderzoekseenheden ... ideaal levens te verbeteren door de ontdekking en ontwikkeling ... PCRU op zoek naar mannen en vrouwen van Japanse ...
(Date:7/30/2014)... -- Hologic, Inc. (NASDAQ: HOLX ) today announced ... 28, 2014. Third Quarter Financial Highlights and ... million, reflecting operational growth of 0.5% and a positive ... in the prior year. , Revenues grew in ... revenues grew 3.5%. , GYN Surgical revenues grew ...
Breaking Medicine Technology:Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 2Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 3Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 4Auxilium Pharmaceuticals, Inc. Announces XIAFLEX Milestone: Partner Asahi Kasei Pharma Corporation Completes Regulatory Submission For Dupuytren's Contracture In Japan 5Gezonde vrijwilligers van Japanse komaf gezocht voor deelname aan Fase I klinisch onderzoek 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 2Hologic Announces Third Quarter Fiscal 2014 Operating Results 3Hologic Announces Third Quarter Fiscal 2014 Operating Results 4Hologic Announces Third Quarter Fiscal 2014 Operating Results 5Hologic Announces Third Quarter Fiscal 2014 Operating Results 6Hologic Announces Third Quarter Fiscal 2014 Operating Results 7Hologic Announces Third Quarter Fiscal 2014 Operating Results 8Hologic Announces Third Quarter Fiscal 2014 Operating Results 9Hologic Announces Third Quarter Fiscal 2014 Operating Results 10Hologic Announces Third Quarter Fiscal 2014 Operating Results 11Hologic Announces Third Quarter Fiscal 2014 Operating Results 12Hologic Announces Third Quarter Fiscal 2014 Operating Results 13Hologic Announces Third Quarter Fiscal 2014 Operating Results 14Hologic Announces Third Quarter Fiscal 2014 Operating Results 15Hologic Announces Third Quarter Fiscal 2014 Operating Results 16Hologic Announces Third Quarter Fiscal 2014 Operating Results 17
... PITTSBURGH , July 14 D3 Radiation Services announced ... service designed to reduce errors in the delivery of radiation therapy--as a ... , , , ... participating clinics and radiation oncology physicists can order a comprehensive audit of ...
... PITTSBURGH , July 14 Mylan Inc. ... Matrix Laboratories Limited has received final approval from the ... New Drug Application (ANDA) for Nabumetone Tablets USP, 500 ... be bioequivalent and, therefore, therapeutically equivalent to Nabumetone Tablets, ...
Cached Medicine Technology:eDataAudit Receives Approval from the American Board of Radiology 2Mylan Receives Approval for Nabumetone Tablets 2
(Date:7/31/2014)... Longmont, Colo. (PRWEB) July 31, 2014 ... snacks, has launched three new products including: a Cacao Nib ... Like all Two Moms in the Raw products, each is ... , “My family is picky, so I’m constantly working on ... our consumers more healthy and tasty choices,” said Shari Leidich, ...
(Date:7/31/2014)... Ohio Presbyterian Retirement Services (OPRS) announced that ... Center, Inc. (Sarah Moore HCC) has joined its family ... Sarah Moore HCC was established in 1892 as a home ... has grown and developed an excellent reputation for high-quality assisted ... has been an integral part of the Delaware community for ...
(Date:7/31/2014)... Francsico, CA (PRWEB) July 31, 2014 ... Sweden have published the largest study ... triage through either teledermoscopy or traditional letter referral ... that smartphone referrals via patent pending iDoc24® technology ... patients with skin cancer while potentially eliminating unnecessary ...
(Date:7/31/2014)... Glaser Pediatric AIDS Foundation (EGPAF) and Riders for ... the delivery of laboratory samples and HIV-related test ... the Northern and Central Zones of Malawi. ... will establish a dependable and coordinated system to ... in health services for the more than 1.3 ...
(Date:7/31/2014)... Delhi, India (PRWEB) July 31, 2014 ... special service for those individuals and organizations against whom ... service as ‘Remove Negative Comments Service’. , About ... said, “We have officially announced the service now, but ... get rid of negative comments for several years.” , ...
Breaking Medicine News(10 mins):Health News:Two Moms in the Raw Launches Three New, Raw, Sprouted 100% Organic Snacks 2Health News:Two Moms in the Raw Launches Three New, Raw, Sprouted 100% Organic Snacks 3Health News:Ohio Presbyterian Retirement Services Welcomes The Sarah Moore HCC into Its Family 2Health News:Ohio Presbyterian Retirement Services Welcomes The Sarah Moore HCC into Its Family 3Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 2Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 3Health News:Smartphone iDoc 24 Technology Speeds Time to Diagnosis and Treatment for Skin Cancer Patients 4Health News:Elizabeth Glaser Pediatric AIDS Foundation partners with Riders for Health in Malawi 2Health News:RankingBySEO Launches a New Service ‘Remove Negative Comments’ 2
... must stop tippling if they want to recover from ... that researched the brain's capacity to regenerate.// ... provides evidence that excessive drinking for a long period ... portal EurekAlert. ,During abstinence, an alcoholic's brain ...
... and literature to spread awareness about the importance of ... including 6,000 women scholars, will be appointed to spread ... said Chaudhry Shahbaz Hussain, federal population planning minister. ... students also aware of these norms, he said. ...
... next-generation medical technology, in conjunction with MYOTECH//, LLC, ... the potential of the MYO-VAD, a cardiac support ... failure. The MYO-VAD restores cardiac output on an ... implanted in approximately three minutes. ,Researchers found ...
... Supermarket chains are recalling some brands of frozen ready meals ... Eye meals//, because of fears that they may contain small ... thousands of ready meals. ,The products came ... Group. Rye Valley foods are one of the country's biggest ...
... from the Italian court, presiding over a milestone case regarding ... paralyzed and terminally ill – who has petitioned the court ... and allow him to die. ,Italy, largely influenced ... and the case has stirred a hornet’s nest, where euthanasia ...
... cells have the ability to trace damaged tissue in the ... on mice.// ,This finding is of great interest ... the human brain, and this knowledge can be put to ... disorders such as traumatic injury. ,Dr. Chay Kuo, ...
Cached Medicine News:Health News:Positive Animal Study on MYO-VAD, Promise for Treatment of Heart Failure 2Health News:Stem Cells In Brain Have Potential For Sensing Damage And To Repair 2
The AcuMatch M-Series modular femoral stem is a unique, innovative three-piece modular stem designed to address even the most complicated of clinical indications....
Exactech's AcuMatch C-Series (cemented femoral stem) is designed to provide solutions to the problems which compromise both the short and long term successful outcome of cemented hip arthroplasty....
The link ribbed hip stem for cementless primary hip replacement surgery....
The uncemented hip joint prosthesis system...
Medicine Products: